• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regulus Therapeutics Inc. - Common Stock (NQ:RGLS)

8.160 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.160
Bid (Size) 8.010 (4)
Ask (Size) 8.150 (5)
Prev. Close 8.160
Today's Range 8.160 - 8.160
52wk Range 0.8301 - 8.345
Shares Outstanding 87,040,335
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of Shareholders
May 15, 2025
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (Nasdaq - XAGE), Southern States Bancshares, Inc. (Nasdaq
May 15, 2025
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+423.1%
+423.1%
1 Month
+0.2%
+0.2%
3 Month
+220.0%
+220.0%
6 Month
+558.1%
+558.1%
1 Year
+369.0%
+369.0%

More News

Read More
REGULUS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Regulus Therapeutics Inc. - RGLS
May 04, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
May 01, 2025
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
May 01, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead
May 01, 2025
Via Stocktwits
Topics Stocks
Wednesday's session: top gainers and losers
April 30, 2025
Via Chartmill
Top stock movements in today's session.
April 30, 2025
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 30, 2025
Via Benzinga
Wednesday's session: gap up and gap down stocks
April 30, 2025
Via Chartmill
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher
April 30, 2025
Via Benzinga
Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
April 30, 2025
Via Benzinga
These stocks that are showing activity before the opening bell on Wednesday.
April 30, 2025
Via Chartmill
S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results
April 30, 2025
Via Benzinga
Topics Stocks
Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis
April 30, 2025
Via Stocktwits
RGLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Regulus Therapeutics Inc. Is Fair to Shareholders
April 30, 2025
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 30, 2025
Via Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether Regulus Therapeutics Inc. Is Obtaining a Fair Price for Its Public Shareholders
April 30, 2025
From Ademi & Fruchter LLP
Via Business Wire
Top movers analysis one hour before the close of the markets on 2025-04-28: top gainers and losers in today's session.
April 28, 2025
Via Chartmill
These stocks are moving in today's session
April 28, 2025
Via Chartmill
These stocks have an unusual volume in today's session
April 01, 2025
Via Chartmill
Top stock movements in today's session.
March 27, 2025
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
March 27, 2025
Via Benzinga
Regulus Therapeutics Stock Shoots Higher After Positive Results From Investigational Drug For Rare Type Of Kidney Disease
March 27, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 27, 2025
Via Benzinga

Frequently Asked Questions

Is Regulus Therapeutics Inc. - Common Stock publicly traded?
Yes, Regulus Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Regulus Therapeutics Inc. - Common Stock trade on?
Regulus Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Regulus Therapeutics Inc. - Common Stock?
The ticker symbol for Regulus Therapeutics Inc. - Common Stock is RGLS on the Nasdaq Stock Market
What is the current price of Regulus Therapeutics Inc. - Common Stock?
The current price of Regulus Therapeutics Inc. - Common Stock is 8.160
When was Regulus Therapeutics Inc. - Common Stock last traded?
The last trade of Regulus Therapeutics Inc. - Common Stock was at 06/24/25 04:00 PM ET
What is the market capitalization of Regulus Therapeutics Inc. - Common Stock?
The market capitalization of Regulus Therapeutics Inc. - Common Stock is 710.25M
How many shares of Regulus Therapeutics Inc. - Common Stock are outstanding?
Regulus Therapeutics Inc. - Common Stock has 710M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap